.

Make Better Decisions

  • Analyze global market entry opportunities
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Citi
Express Scripts
Johnson and Johnson
Moodys
QuintilesIMS
Covington
UBS
Harvard Business School
Mallinckrodt
Farmers Insurance

Generated: December 16, 2017

DrugPatentWatch Database Preview

Details for Patent: 9,149,579

« Back to Dashboard

Which drugs does patent 9,149,579 protect, and when does it expire?


Patent 9,149,579 protects AUVI-Q and is included in one NDA.

This patent has one hundred patent family members in fourteen countries.

Summary for Patent: 9,149,579

Title:Devices, systems and methods for medicament delivery
Abstract: An apparatus includes a movable member and a valve coupled to the movable member. The movable member is configured to be disposed within a housing of a medical device and has a first end portion and second end portion. A portion of the first end portion is configured to define a portion of a boundary of a gas chamber. The first end portion defines an opening configured to be in fluid communication between the gas chamber and an area outside the gas chamber. The second end portion is configured to be coupled to a needle configured to deliver a medicament into a body. The valve is configured to selectively allow fluid communication between the gas chamber and the area outside the gas chamber through the opening defined by the first end portion of the movable member.
Inventor(s): Edwards; Evan Thomas (Gordonsville, VA), Edwards; Eric Shawn (Moseley, VA), Licata; Mark J. (Doswell, VA)
Assignee: kaleo, Inc. (Richmond, VA)
Application Number:13/748,728
Patent Claim Types:
see list of patent claims
Dosage form; Use; Composition;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Kaleo IncAUVI-QepinephrineINJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS201739-002Aug 10, 2012BXRXYesYes► Subscribe► SubscribeMETHOD OF TREATING ALLERGIC REACTION VIA INJECTION► Subscribe
Kaleo IncAUVI-QepinephrineINJECTABLE;INTRAMUSCULAR, SUBCUTANEOUS201739-001Aug 10, 2012BXRXYesNo► Subscribe► SubscribeMETHOD OF TREATING ALLERGIC REACTION VIA INJECTION► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 9,149,579

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,361,029Devices, systems and methods for medicament delivery► Subscribe
8,313,466Devices, systems and methods for medicament delivery► Subscribe
7,918,823Devices, systems and methods for medicament delivery► Subscribe
8,544,645Devices, systems and methods for medicament delivery► Subscribe
9,278,182Devices, systems and methods for medicament delivery► Subscribe
9,327,077Medical injector with compliance tracking and monitoring► Subscribe
8,226,610Medical injector with compliance tracking and monitoring► Subscribe
9,278,177Medical injector with compliance tracking and monitoring► Subscribe
9,259,539Devices, systems and methods for medicament delivery► Subscribe
8,123,719Devices, systems and methods for medicament delivery► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 9,149,579

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Australia2004325202► Subscribe
Australia2006210865► Subscribe
Australia2007245139► Subscribe
Australia2009200841► Subscribe
Australia2009246525► Subscribe
Australia2012201481► Subscribe
Australia2015264857► Subscribe
Canada2586525► Subscribe
Canada2594627► Subscribe
Canada2644547► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
UBS
Fuji
Cerilliant
Novartis
Citi
Farmers Insurance
AstraZeneca
Healthtrust
Dow

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot